Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study
about
Multimorbidity in chronic disease: impact on health care resources and costsUpdate and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum.Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trialEnvironmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes.Thyroid function and risk of type 2 diabetes: a population-based prospective cohort studyClinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular DiseasePhysical activity, sedentary behaviors and the incidence of type 2 diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis (MESA).Comparing glycaemic benefits of Active Versus passive lifestyle Intervention in kidney Allograft Recipients (CAVIAR): study protocol for a randomised controlled trialSocial facilitation maintenance treatment for adults with obesity: study protocol for a randomised-controlled feasibility study (SFM study)Inclusion of walnut in the diets of adults at risk for type 2 diabetes and their dietary pattern changes: a randomized, controlled, cross-over trial.Clinical impact of lifestyle interventions for the prevention of diabetes: an overview of systematic reviewsPatient Perceptions About Prediabetes and Preferences for Diabetes Prevention.'Knowing what Matters in diabetes: Healthier below 7': results of the campaign's first 10 years (part 2), participants without known diabetes history.Two-year follow-up of 4 months metformin treatment vs. placebo in ST-elevation myocardial infarction: data from the GIPS-III RCT.Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium.Cardiac Computed Tomography Angiographic Findings as Predictors of Late Heart Failure in an Asymptomatic Diabetic Cohort: An 8-Year Prospective Follow-Up Study.Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials.Doctor Referral of Overweight People to a Low-Energy Treatment (DROPLET) in primary care using total diet replacement products: a protocol for a randomised controlled trial.Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.The Case for Diabetes Population Health Improvement: Evidence-Based Programming for Population Outcomes in Diabetes.Effect of lifestyle improvement program on the biomarkers of adiposity, inflammation and gut hormones in overweight/obese Asian Indians with prediabetes.Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study.Metformin; a review of its history and future: from lilac to longevity.Drugs to treat obesity: do they work?Genetically Driven Hyperglycemia Increases Risk of Coronary Artery Disease Separately From Type 2 Diabetes.Reducing the prevalence of dysglycemia: is the time ripe to test the effectiveness of intervention in high-risk individuals with elevated 1 h post-load glucose levels?Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity.Biopsychosocial Aspects of Weight Management in Type 1 Diabetes: a Review and Next Steps.Effectiveness and cost-effectiveness of interventions that cause weight loss and reduce the risk of cardiovascular disease.Can Cardiovascular Epidemiology and Clinical Trials Close the Risk Management Gap Between Diabetes and Prediabetes?Survey of primary care providers' knowledge of screening for, diagnosing and managing prediabetes.Metformin Use in Prediabetes Among U.S. Adults, 2005-2012.Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year.Oral glucose tolerance test predicts increased carotid plaque burden in patients with acute coronary syndromeEngagement and outcomes in a digital Diabetes Prevention Program: 3-year updateLifestyle precision medicine: the next generation in type 2 diabetes prevention?Practical partnered research to improve weight loss among overweight/obese veterans: lessons from the trenches.Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS).Association of Waist Circumference Gain and Incident Prediabetes Defined by Fasting Glucose: A Seven-Year Longitudinal Study in Beijing, China.
P2860
Q26741437-9E51816F-4C4F-4D4D-B3B5-7D6D9BB04078Q30392979-28E5958C-E0AC-4A6D-AA35-568E27674D5CQ33765636-BE21B9AD-F6B9-4223-B929-B9FE2464FF65Q33916655-565D5562-6D93-4B7B-92A2-6EB445C87840Q36148822-9E2DB58B-A3C9-420A-BCB1-3BF18A4436BCQ36153812-4F646A0D-8351-4E5C-A332-B44F34FDABDCQ37063715-A4A579A7-9B33-41C2-BB83-3AE2B36B898BQ37196150-03E5B1AE-94EA-4A34-9A70-84767F6BFBE4Q37236678-E63E2822-DC7A-4F23-B9D7-B609FB43C5D6Q37356056-8D30DF84-3035-4EE0-8482-8C9A38E3DC54Q37576845-AD01CC27-5070-44AF-82C0-9DDEE29F6632Q37582154-D2E1F1E7-5BDA-4C30-A941-FE76B5367187Q37722621-B49840D3-92BC-4182-A791-A3108056A655Q38373147-AB4C2F81-8712-491F-A1D3-20BBDBBF6DE2Q38377128-12C84A13-01E0-4A1C-BA44-0BA6A7DCD382Q38619761-4EB890D6-A7EF-47B0-A920-B643D0150B40Q38627117-60E23633-BF67-47F5-99EF-0B2EA050DAAAQ38638668-5FC8C753-AF9A-4F1E-90FD-A5DD587F9024Q38645269-66F7A184-58BE-4259-B6D5-65CA8FD8D69DQ38676372-C89D3168-2612-4E45-B607-7A1A9AC25829Q38723058-689ACE28-FC41-4B16-BB48-0053FA74720BQ38744831-817A3569-59E4-4822-AC89-FC6DDD35223BQ38753187-F56AB134-5E87-4573-9E47-666F5978B5C5Q38774878-5960EDA9-B386-40F5-B71F-5097551E4697Q38800281-130372E2-AD53-441A-9851-68DED60998E4Q38905127-A35CBC40-0F5C-472A-BF37-54C42A101ADAQ38998224-A90D3718-BFC6-44B2-ADE4-D5E48921AC4DQ39376655-C336F3B5-23DF-4D1D-AA9E-DFB2A867212EQ39404081-B314EAEE-667A-4559-8500-1BF0EE595B4AQ39633381-C0F2F396-8E2E-4924-AE46-C8D0BC3395FBQ40098483-99C9BBED-F080-4DB9-99DA-4CEDF0B1792DQ40113745-E4193761-BB89-4F6A-99B7-5F272CDD17F2Q40260154-9EEE5EF9-AEA6-40D5-B2D0-4DC8DF898A06Q41551599-ABF2FA78-0BF9-4112-87A1-628B435767BCQ41561279-3693C407-4E6F-4564-8D51-A1BD3A491B16Q41677567-C7AA13F1-CEC9-4011-A57C-2B8E336DFBEFQ41691100-AD1F4AF7-573A-43A7-9500-82468FF8C7DCQ42370785-F9070833-920A-47E9-8B99-05F7241B6A88Q46313904-19170EEF-2C1B-486C-8EDC-31C568BD1039Q46768472-4ED74334-E8D1-41F0-9A8B-03CDF5B107A1
P2860
Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Long-term effects of lifestyle ...... vention Program Outcomes Study
@ast
Long-term effects of lifestyle ...... vention Program Outcomes Study
@en
type
label
Long-term effects of lifestyle ...... vention Program Outcomes Study
@ast
Long-term effects of lifestyle ...... vention Program Outcomes Study
@en
prefLabel
Long-term effects of lifestyle ...... vention Program Outcomes Study
@ast
Long-term effects of lifestyle ...... vention Program Outcomes Study
@en
P2860
P1476
Long-term effects of lifestyle ...... vention Program Outcomes Study
@en
P2860
P304
P356
10.1016/S2213-8587(15)00291-0
P577
2015-09-11T00:00:00Z